Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
31 hedge funds and large institutions have $20.8M invested in Roivant Sciences Ltd. Warrant in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
14% less funds holding
Funds holding: 36 → 31 (-5)
18% less capital invested
Capital invested by funds: $25.5M → $20.8M (-$4.67M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$236K |
| 2 |
D.E. Shaw & Co
New York
|
+$127K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$105K |
| 4 |
Walleye Capital
New York
|
+$34.8K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$9.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$471K |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$316K |
| 3 |
SAMU
SONA Asset Management (US)
New York
|
-$193K |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$44K |
| 5 |
TCA
Taconic Capital Advisors
New York
|
-$41K |
ROIVW Hedge Fund Activity: Q2 2022 in Review
31 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q2 2022, worth a combined $20.8M — down 18% from $25.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ROIVW and 3 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was LMR Partners, adding an estimated $236K. The largest seller was Beryl Capital Management, exiting entirely with an estimated $471K sold.
- 31 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q2 2022, down from 36 in Q1 2022.
- Funds reported $20.8M of Roivant Sciences Ltd. Warrant stock for Q2 2022, down 18% quarter-over-quarter.
- 3 funds opened new Roivant Sciences Ltd. Warrant positions in Q2 2022 and 8 closed out, a net change of -5 holders.
- The largest Roivant Sciences Ltd. Warrant buyer in Q2 2022 was LMR Partners, an estimated $236K added.
- The largest Roivant Sciences Ltd. Warrant seller in Q2 2022 was Beryl Capital Management, an estimated $471K sold.
Based on aggregated 13F filings for Q2 2022.